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ABSTRACT
Aim of study. We investigated sex differences in ischaemic stroke patients treated with intravenous alteplase. 
Clinical rationale for study. We suggest that it is necessary to improve care for women with atrial fibrillation. Our data suggests 
that closer evaluation of treatment for ischaemic stroke in men and women is needed, preferably in the form of a prospective study. 
Materials and methods. This was a multicentre analysis of 1,830 ischaemic stroke patients treated with alteplase from 2004 to 
2012. Data was prospectively collected in the Safe Implementation of Treatments in Stroke (SITS) registry. The main outcome 
measures were symptomatic intracerebral haemorrhage (sICH) within 36 hours of treatment, three months of functional inde-
pendence, and mortality. 
Results. Women were significantly older (mean age 71.3 vs 66.2 years; p < 0.01), more often suffered from hypertension (78.3% 
vs 70.1%; p < 0.01) and cardio-embolic strokes (34.7% vs 27.1%; p < 0.01), and presented heavier baseline deficits. There were no 
differences in sICH, but after three months fewer women were functionally independent (46.5% vs 53.3%; p < 0.01) and women 
had higher mortality (26.0% vs 19.7%; p < 0.01). 
Conclusions: Of the ischaemic stroke patients treated with intravenous thrombolysis, women had worse long-term outcomes 
than men. This discrepancy may be explained by the older age and higher proportion of cardio-embolic strokes with more 
severe baseline deficits. However, multiple logistic analysis did not show that sex itself had an impact on the greater mortality 
in women after a stroke, or on the poorer prognosis. 
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Introduction 
In recent years, a lot of research has been published looking 
into ischaemic stroke’s epidemiology, prognosis, risk factors, 
pathogenesis, clinical picture and course, as well as its treatment 
and sex-dependent outcomes [1]. Many studies have shown that 
women suffer from more severe strokes than men, and have 
less favourable prognoses, something which is additionally 
modified by their home country’s level of development [2–9]. 
Women also appear to be less often treated with intraveno-
us thrombolysis [9–13]. It is uncertain if they equally benefit 
from intravenous and intra-arterial thrombolysis treatment 
[12–17]. One should also take into account specific national 
or regional differences in patients’ profiles [18].
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2004 and December 2012 in many centres in Poland. The 
analysed group included 819 women (44.8%). Women were 
significantly older (mean age 71.3 vs 66.2 years), were more 
frequently dependent before a stroke (9.3% vs 3.1%), were 
more often burdened with AF (35.8% vs 26.3%) and hyper-
tension, but were less often smokers (13.3% vs 33.9%) (Tab. 1). 
Women suffered more severe strokes (median baseline NIHSS 
score 13 vs 11). Stroke aetiology in women was more often 
cardioembolic (34.7% vs 27.1%) (Tab. 1), although they used 
anticoagulants less often (3.8% vs 4.2%).
Women had significantly longer onset-to-door time (ODT) 
(median 70 vs 62 min) and longer onset-to-treatment time 
(OTT) (median 160 vs 154 min), with a borderline difference 
in door-to-treatment time (DTT) (median 75 vs 80 min, 
p = 0.05). Their stroke unit stay was significantly shorter (me-
dian 8.7 vs 9.1 days). There were no significant differences in 
the prescription rates of hypotensive medications, aspirins, 
vitamin K antagonists or new oral anticoagulants, but women 
were less likely than men to be prescribed statins on discharge 
from hospital (83.4% vs 90.1%).
Women had significantly higher mortality, both at day 
7 (15.5% vs 9.6%) and three months after the onset of symp-
toms (26.0% vs 19.7%) (Tab. 2). This discrepancy was not 
modified by the presence of AF, hypertension or diabetes. 
There were no significant differences in the occurrence of 
sICH according to the ECASS (European Cooperative Acute 
Stroke Study) or the SITS definition (Tab. 2) [19]. However, 
a tendency towards a higher occurrence of sICH according 
to ECASS in women was particularly marked in subgroups 
of patients with diabetes, with heart failure, with aspirin use 
before stroke, and with disability before stroke (Tab. 3).
Multiple logistic analysis did not confirm that sex itself 
had an impact on greater mortality in women after a stroke 
or a worse prognosis (Tab. 4).
Discussion 
In line with data from other cohorts, we found that women 
with acute ischaemic stroke treated with tPA are older than 
men and more often suffer from strokes of cardioembolic 
aetiology [7, 9, 17, 25–29]. However, the mean age at stroke 
onset among Polish women was seven years lower than in 
Sweden (mean age 71.3 vs 78.4 years). In other words, female 
Polish patients experienced a stroke seven years earlier than 
female Swedish patients [30]. Female Polish patients, despite 
a higher proportion of pre-stroke AF, used oral anticoagulants 
as frequently as men (3.8% vs 4.2%). Similarly to Swedish pa-
tients [30], no differences were found in the prescription rate 
of anticoagulants after an ischaemic stroke. Higher proportions 
of AF and hypertension in women have also been reported in 
other cohorts [9, 28, 29, 31]. 
Probably because of all the abovementioned reasons, the 
neurological condition on admission of women was significan-
tly worse than men [30, 32, 33]. We observed that the ODT, 
Clinical rationale for the study
The aim of this study was to investigate sex-related dif-
ferences in patient profiles and outcomes among Caucasian 
ischaemic stroke patients from Polish centres treated with 
intravenous thrombolysis.
Materials and methods 
This is a retrospective multicentre analysis of 1,830 con-
secutive ischaemic stroke patients treated with intravenous 
alteplase (tPA) in Polish centres from 1 January 2004 to 
31 December 2012. The data was prospectively recorded in the 
Safe Implementation of Treatments in Stroke – International 
Stroke Thrombolysis Registry [19]. The main outcome mea-
sures were: functional independence (0–2 in modified Rankin 
Scale score-mRS) at three months; sICH within 36 hours of 
treatment; and three-month mortality [19]. Dependency was 
defined as an mRS score of 3–5 [20].
Stroke events were defined according to the World Health 
Organisation’s criteria, and stroke was confirmed in all patients 
by neuroimaging [21]. 
Stroke subtypes were classified on admission according 
to the Trial of Org10172 in Acute Stroke Treatment (TOAST) 
criteria [22]. Stroke severity was measured using the National 
Institutes of Health Stroke Scale score (NIHSS) on admission 
and at discharge. Conventional stroke risk factors, including 
hypertension, diabetes mellitus, atrial fibrillation (AF), hyper-
lipidemia and tobacco smoking, were defined as self-reported 
in previous medical records or newly diagnosed. Obesity was 
defined as a body mass index ≥ 30kg/m2. Pre-stroke mRS, at 
discharge, and three months after the stroke, were assessed 
during an interview with the patient or his or her proxy. 
Statistical analysis 
Continuous variables are presented as mean with standard 
deviation or median and quartiles, depending on the normality 
of data distribution. Categorical variables are presented as 
a number of observations with percentage. For comparisons 
between men and women, Mann-Whitney U tests and Fisher’s 
exact tests were used, as appropriate [23]. A p value = 0.05 was 
considered significant. All analyses were performed in R v. 
3.4.0. [24]. A multiple logistic regression model, which was 
adjusted for age, onset-to-door time, door-to-treatment time, 
presence of hypertension, diabetes, AF, smoking (currently), 
and baseline mRS score before stroke (0 and 1 only), was applied 
to identify factors contributed considerably to the main endpo-
ints (death, mRS after three months, sICH according to SITS).
Results 
The studied population included 1,830 consecutive ischa-
emic stroke patients treated with alteplase between January 
274
Neurologia i Neurochirurgia Polska 2020, vol. 54, no. 3
www.journals.viamedica.pl/neurologia_neurochirurgia_polska
Table 1. Sex differences in risk factors and clinical characteristics among patients with ischaemic stroke treated with intravenous thrombolysis
Characteristics Men Women p-value
Cases, n (%) 1.011 (55.2) 819 (44.8) < 0.01
Age, years, mean (SD) 66.2 (11.0) 71.3 (11.6) < 0.01
Atrial fibrillation, n (%) 262 (26.3) 289 (35.8) < 0.01
Congestive heart failure, n (%) 214 (21.5) 151 (18.8) 0.16
Hyperlipidemia, n (%) 317 (33.4) 254 (32.6) 0.76
Hypertension, n (%) 700 (70.1) 637 (78.3) < 0.01
Diabetes mellitus, n (%) 184 (18.4) 171 (21.1) 0.15
Previous stroke, n (%) 138 (13.8) 107 (13.2) 0.78
Smoking – previous, n (%) 189 (28) 47 (6.8) < 0.01
Smoking – current, n (%) 324 (33.9) 106 (13.3) < 0.01
Baseline NIHSS score, median (Q1-Q3) 11 (7–16) 13 (7.5-18) < 0.01
SBP mean, mm Hg (SD) 151.4 (20.8) 152.4 (20.4) 0.18
DBP mean, mm Hg (SD) 85.7 (13.1) 83.7 (12.9) < 0.01
Glucose, mg/dl, (SD) 131.1 (47.3) 135.5 (49.3) 0.01
Large-vessel disease, CAS, n (%) 155 (16.6) 69 (9.3) < 0.01
Large vessel disease, other, n (%) 301 (32.2) 249 (33.4) 0.64
Cardio-embolic, n (%) 253 (27.1) 259 (34.7) < 0.01
Lacunar stroke, n (%) 57 (6.1) 57 (7.6) 0.24
Other/unusual n (%) 35 (6.0) 56 (4.7) 0.28
Unknown, n (%) 111 (11.9) 76 (10.2) 0.31
SBP — systolic blood pressure; DBP — diastolic blood pressure
Table 2. Sex differences in outcomes at three months after ischaemic stroke treated with alteplase
Outcome Men Women p-value
Death, n (%) 199 (19.7) 213 (26.0) < 0.01
mRS 0-1, n (%) 358 (35.4) 245 (29.9) < 0.01
mRS 0-2, n (%) 539 (53.3) 381 (46.5) < 0.01
Intracerebral haemorrhage according to ECASS def., n (%) 45 (4.7) 50 (6.5) 0.11
Intracerebral haemorrhage according to SITS def., n (%) 14 (1.5) 16 (2.0) 0.36
ECASS — European Cooperative Acute Stroke Study; SITS — Safe Implementation of Treatments in Stroke; mRS — modified Rankin Scale score
Table 3. Frequency of symptomatic intracerebral haemorrhage (sICH) according to ECASS definition in women and men depending on presence of additio-
nal factor





with factor without factor with factor without factor
Diabetes,  n (%) 9 (5.3) 36 (4.6) 13 (8.0) 36 (6.0) 1.36 (CI 0.52–3.08)
Atrial fibrillation, n (%) 20 (8.2) 23 (3.3) 27 (9.9) 22 (4.5) 1.31 (CI 0.74–2.56)
Hypertension, n (%) 8 (4.8) 12 (4.2) 42 (7.0) 32 (4.8) 1.4 (CI 0.86–2.27)
Heart failure, n (%) 11 (5.5) 32 (4.3) 15 (10.9) 34 (5.5) 1.47 (CI 0.66–3.38)
Aspirin use before stroke,  n (%) 12 (4.0) 28 (4.4) 21 (8.4) 28 (5.6) 1.56 (CI 0.75–3.28)
Disability before stroke, (mRS > 
1) n (%)
3 (4.5) 39 (4.5) 14 (11.3) 32 (5.1) 1.28 (CI 0.78–2.05)
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 Table 4. Multiple regression logistic model adjusted for age, onset-to-door time (OTD), door-to-treatment time (DTT), presence of hypertension, diabetes 
mellitus, AF, smoking (current), score 0–1 in mRS before stroke, initial stroke severity on NIHSS scale 
Variable OR ± 97.5 CI 2.5% CI 97.5% CI
Death 1.2104 0.8752 1.6736
Intracerebral haemorrhage according to SITS def. 1.2493 0.5059 3.12222
mRS 0–1 after 3 months 1.0037 0.7803 1.2909
mRS 0–2 after 3 months 1.0137 0.7851 1.3098
OR — odds ratio; CI — 95% confidence interval; SITS — Safe Implementation of Treatments in Stroke; mRS — modified Rankin Scale score
as well as the OTT, in women was on average several minutes 
longer than in men. This might be caused by their older age, 
more frequent functional dependence, and more frequent 
living alone [32]. The difference may not be of major clinical 
importance overall, but it still deserves to be addressed. At-
tempts should be made to equip older women who live alone 
with the knowledge of how to recognise stroke and how to 
react. It might also be profitable to consider providing them 
with a special device to facilitate communication with ambu-
lances in case of emergency. As there were no differences in 
DTT, we can assume that the processing of patients qualified 
for tPA is equal for both sexes while in hospital.
Yeo et al. [15] observed, in a group of 2,460 ischaemic 
stroke patients treated with intravenous alteplase, that if the 
outcome of women improved significantly (a 10 or more 
points reduction in NIHSS scale) within 2–24 hours, there 
was a doubled chance of regaining full independence at three 
months after an ischaemic stroke. This illustrates the necessity 
of women receiving particularly good care within the first 
24 hours from the onset of an ischaemic stroke. If such care 
were to become standard, then the number of women with 
greater independence at three months would increase. 
Our study has some limitations. It used data from a volun-
tary multicentre registry. The evaluation of control CT scan 
was performed on site, and the diagnosis of sICH was made 
at the discretion of an attending physician. It is impossible to 
determine how many patients were not reported, and why. 
Because only a fraction of Polish stroke centres participate 
in the SITS, one may expect that our results are generalisable 
to dedicated stroke units, but probably not fully to all Polish 
stroke units. Nonetheless, the registry provides the best avai-
lable multicentre real life data. 
Clinical implications/future directions
Our findings confirm that there are several important 
sex-related differences in ischaemic stroke patients treated 
with intravenous alteplase. Although women do not seem to 
be at a clearly increased risk of intracerebral haemorrhage, 
they more often have a poor long-term outcome and higher 
mortality. This discrepancy may be to some extent explained 
by the older age and higher proportion of cardio-embolic 
strokes with more severe baseline deficit. 
One may assume that the optimisation of primary preven-
tion, improved stroke awareness, and improved communica-
tion with ambulance dispatchers could reduce the gap between 
men and women. Therefore, specific central health policies 
should be encouraged and properly implemented. 
Our data suggests that closer evaluation of the treatment 
of ischaemic stroke in men and women in Poland is needed, 
preferably in the form of a prospective study. It is also necessary 
to improve care for women with AF.
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